U.S. Electrical Stock News

Madrigal Pharmaceuticals (NasdaqGS:MDGL) entered an exclusive global license agreement with Pfizer for the MASH candidate ervogastat. The deal is intended to expand Madrigal's treatment pipeline focused on metabolic dysfunction associated steatohepatitis. Around the same period, multiple insiders, including the CEO and board directors, recorded sales of Madrigal shares. These transactions arrive alongside the licensing news, giving investors fresh information on both pipeline direction and...

CNH Industrial (NYSE:CNH) has introduced its new R4 autonomous robot to support specialty crop farming. The R4 is aimed at helping growers address labor shortages across tasks in orchards, vineyards, and other high value crops. The launch advances the company’s automation push within agriculture equipment and specialty crop technology. CNH Industrial, trading at $10.85, is rolling out the R4 at a time when specialty crop producers continue to face tight labor conditions. The stock has...

GDS Holdings has called an Extraordinary General Meeting for February 24, 2026, seeking approval to amend its Articles of Association and increase founder William Huang’s Class B voting power from 20 to 50 votes per share, boosting his effective control from about 36.2% to about 58.6% on key decisions. The company links this proposed governance shift to regulatory and client demands for clear Chinese national control over data center operators, aiming to safeguard access to sensitive...

Curtiss-Wright recently expanded its defense and aerospace footprint through a collaboration with Green Hills Software on a high-performance, safety-certifiable COTS computing solution for critical avionics, alongside earlier validation of its PacStar tactical edge servers for Azure Local in November 2025. By pairing safety-certifiable avionics computing with cloud-enabled tactical edge servers, Curtiss-Wright is positioning its portfolio at the intersection of mission-critical reliability...

Rocket Lab (RKLB) is back in focus after delivering its Hungry Hippo captive fairing to Wallops Island in Virginia, marking visible hardware progress on the Neutron rocket shortly after a routine Stage 1 tank test rupture. See our latest analysis for Rocket Lab. Those Neutron updates arrive as the share price consolidates after a strong run. The 30 day share price return is 21.62% and the 90 day gain is 36.04%, while the 1 year total shareholder return above 200% and very large 3 and 5 year...

GE Vernova (GEV) closed out FY 2025 with Q4 revenue of US$10.96b and basic EPS of US$13.57, alongside net income excluding extra items of US$3,664m, capping a year in which trailing twelve month EPS reached US$17.96 on revenue of US$38.07b. Over the past six quarters, the company has seen quarterly revenue move from US$8,913m in Q3 2024 to US$10,558m in Q4 2024 and then to US$10,956m in Q4 2025, while basic EPS shifted from a loss of US$0.35 in Q3 2024 to US$1.75 in Q4 2024 and then to...

If you are wondering whether Ciena’s share price still offers value after its strong run, or if most of the easy gains are already behind it, this article walks through what the current valuation looks like. Ciena’s stock closed at US$253.53, with returns of 10.2% over 7 days, 6.4% over 30 days, 3.0% year to date, 199.5% over 1 year and 392.6% over 3 years. This naturally raises questions about risk, reward and how much optimism is already reflected in the price. Recent attention on Ciena...

CG Oncology has been gaining attention as its flagship BOND-003 therapy progresses through phase 3 trials for high-risk BCG-unresponsive non-muscle invasive bladder cancer, aiming to offer a bladder-sparing treatment option. The company’s focus on addressing this difficult-to-treat patient group highlights its potential role in reshaping how bladder cancer is managed if trial outcomes support its approach. Next, we’ll examine how the advanced phase 3 progress of BOND-003 shapes CG Oncology’s...

In recent days, Barclays upgraded PTC Therapeutics to an Overweight rating, while other brokers continued to rate the biotech as Outperform, underscoring growing analyst optimism around the company’s rare disease portfolio. This convergence of positive views, anchored in PTC’s therapies for conditions such as Duchenne muscular dystrophy and AADC deficiency, highlights how analyst sentiment can crystallize around a focused clinical pipeline. Next, we’ll examine how this strengthened analyst...

Affirm Holdings (NasdaqGS:AFRM) has partnered with Bolt to integrate its buy now, pay later (BNPL) options directly into Bolt powered e commerce checkouts. The company has also signed a partnership with Fiserv that connects its BNPL offering to a range of debit card programs and financial institution clients. Affirm has applied for a limited bank charter that could allow deposit based funding and new lending products, subject to regulatory approval. Affirm comes into these developments with...

Spotify Technology (NYSE:SPOT) reports a record industry payout of over US$11b to artists and publishers in 2025. The company introduces new artist verification tools aimed at limiting AI content exploitation on its platform. Spotify expands video content with documentary style series focused on artists and music culture. Spotify Technology, which runs one of the largest global audio streaming platforms, is tying its brand closely to creator payouts and content integrity. The record US$11b...

Medical Properties Trust (NYSE:MPW) has relocated its corporate headquarters to a new address in Alabama. The move marks an official change in the company’s primary base of operations. Medical Properties Trust focuses on investing in hospital and healthcare facilities, with tenants that operate across a range of medical services. A headquarters relocation can affect how leadership is organized, how teams work together and how resources are allocated across the portfolio. For you as an...

ExxonMobil (NYSE:XOM) plans to close its Fife Ethylene Plant in Scotland, affecting more than 400 jobs. The company is advancing carbon capture and storage projects along the U.S. Gulf Coast, targeting multiple sites to be operational by 2026. Recent contracts support expansion of ExxonMobil's CCS footprint in industrial hubs on the Gulf Coast. For you as an investor, these moves sit at the intersection of ExxonMobil's traditional chemicals business and its push into lower carbon services...

POET Technologies (NasdaqCM:POET) has drawn fresh attention after completing a US$150.000006 million registered direct follow on equity offering at US$7.25 per share, issuing 20,689,656 new common shares to investors. See our latest analysis for POET Technologies. The follow on offering and shelf registration have arrived during a weaker patch for the stock, with a 7 day share price return of 14.27% decline and a year to date share price return of 16.90% decline. However, the 1 year total...

Innodata Inc. recently announced it was selected to provide high-quality training data, multimodal data engineering, and generative-AI workflow support to Palantir Technologies, powering AI-enabled video analysis for rodeo sports across thousands of hours of footage. Coupled with Innodata’s prior award under the Missile Defense Agency’s SHIELD program, these wins highlight the company’s role in complex, high-stakes AI and defense data workloads. We’ll now explore how this expanded role as...

Tripadvisor (TRIP) has put its AI capabilities in the spotlight, teaming up with Best Western Hotels & Resorts on a new “Go for the Goal” trip planning platform built around the 2026 global soccer tournament. See our latest analysis for Tripadvisor. These AI trip planning efforts come as Tripadvisor’s share price, last closing at US$13.42, shows weak momentum, with a 30 day share price return of 8.33% and a 90 day share price return of 16.44% decline. The 1 year total shareholder return of...

L3Harris Technologies (LHX) closed out FY 2025 with fourth quarter revenue of US$5.6b and basic EPS of US$1.60, alongside net income of US$300m, while trailing twelve month EPS stood at US$8.57 on revenue of US$21.9b and net income of US$1.6b. Over the past six quarters, the company has seen quarterly revenue move from US$5.3b in Q3 2024 to US$5.6b in Q4 2025, with basic EPS ranging between US$1.60 and US$2.47 and net income between US$300m and US$462m, setting a clear earnings profile for...

In January 2026, Capital One Financial reported fourth-quarter 2025 results showing net interest income of US$12,466 million and net income of US$2,134 million, alongside net charge-offs rising to US$3,833 million from US$2,884 million a year earlier. The earnings miss versus analyst expectations, coupled with higher credit losses, has already drawn legal scrutiny and prompted revisions to analyst earnings forecasts. Next, we will examine how the earnings miss and rising net charge-offs...

Sysco stock: recent performance snapshot Sysco (SYY) has been drawing attention after a strong run in its share price, with gains over the past week, month, and past 3 months prompting investors to reassess the company’s current valuation and fundamentals. See our latest analysis for Sysco. That recent momentum, including a 13.4% 30 day share price return and a 17.9% 1 year total shareholder return, puts Sysco’s current US$84.11 share price in the context of both short term interest and...

Hercules Capital (HTGC) has been drawing investor attention after a period of mixed recent returns, with a small gain over the past 3 months but declines over the past year and year to date. See our latest analysis for Hercules Capital. At a share price of US$18.68, Hercules Capital’s short term picture looks mixed, with modest recent share price moves contrasted by a stronger backdrop over time. This is highlighted by a 3 year total shareholder return of 73.50% and a 5 year total shareholder...

West Bancorporation (WTBA) closed out FY 2025 with fourth quarter revenue of US$23.3 million and basic EPS of US$0.44, capping a trailing twelve month stretch that produced US$95.2 million in revenue and US$1.92 in EPS. Over that period, revenue moved from US$78.8 million to US$95.2 million while EPS rose from US$1.43 to US$1.92, indicating that earnings have grown faster than revenue as the bank converted more of its income into profit. With net profit margins higher over the last year and...

Sherwin-Williams (SHW) has wrapped up FY 2025 with fourth quarter revenue of US$5,595.9 million and basic EPS of US$1.94, alongside trailing twelve month revenue of US$23.6 billion and EPS of US$10.37 that frame the full year earnings picture. Over recent periods, revenue has moved from US$5,297.2 million in Q4 2024 to US$5,595.9 million in Q4 2025, while quarterly EPS has been reported at US$1.92 and US$1.94 respectively, giving investors a clear read on how top line and per share profits...

Anthropic is pursuing a $20b fundraising round that is larger than its original goal, drawing fresh attention to AI infrastructure capacity. IREN (NasdaqGS:IREN) is expanding its AI infrastructure partnerships, including a long term agreement with Microsoft focused on high performance computing. These developments connect a major AI model developer’s capital plans with growing demand for data center resources that IREN is working to supply. For investors tracking AI related names, IREN now...

First Financial Bancorp (FFBC) closed out FY 2025 with fourth quarter revenue of US$228.7 million and EPS of US$0.65. Trailing twelve month revenue was US$861.8 million and EPS was US$2.68. Over the past year, the company’s revenue increased from US$756.1 million to US$861.8 million and EPS moved from US$2.42 to US$2.68. This coincided with earnings growth of 11.7% over the last 12 months, compared with a 5-year average of 6.8% per year. Investors may weigh this growth and a 3.47% dividend...